chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Eye pain, Fatigue, Feeling cold, Feeling of body temperature change
Clinical narrative: Pain at site of injection; cold sweat; body aches; muscle soreness; Headache; swollen lymph nodes; pain at injection site was worsening; tender to touch but no inflammation; Insomnia; Fatigue; chills; This is a spontaneous report from a contactable nurse (patient).  A 29-year-old male patient received the 1at dose of bnt162b2 (BNT162B2, lot #: EJ1685) intramuscular at single dose at left arm on 21Dec2020 10:45 PM for Covid-19 immunization, administered at hospital.  Medical history included none. No known allergies. The patient's concomitant medications were not reported. He received no other vaccine in four weeks. On 21Dec2020 23:00 he experienced fatigue and chills around and pain at site of injection and took Advil 600mg taken for relief. On 22Dec2020 08:00 he experienced chills, body aches, muscle soreness, headache, swollen lymph nodes, and pain at injection site was worsening; tender to touch but no inflammation. On 22Dec2020 12:00 he experienced cold sweat and on 22Dec2020 he experienced insomnia, and took Tylenol 1,000mg. On 22Dec2020 21:30 the symptoms were less severe and took Advil 600mg. On 23Dec2020 05:00 all symptoms resolved. The patient was not diagnosed with COVID-19 prior to vaccination and was not Covid tested post vaccination. The patient recovered from all events in Dec2020. The reporter assessed the events as non-serious.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hyperhidrosis, Injection site pain, Lymphadenopathy, Myalgia
Clinical narrative: Pain at site of injection; cold sweat; body aches; muscle soreness; Headache; swollen lymph nodes; pain at injection site was worsening; tender to touch but no inflammation; Insomnia; Fatigue; chills; This is a spontaneous report from a contactable nurse (patient).  A 29-year-old male patient received the 1at dose of bnt162b2 (BNT162B2, lot #: EJ1685) intramuscular at single dose at left arm on 21Dec2020 10:45 PM for Covid-19 immunization, administered at hospital.  Medical history included none. No known allergies. The patient's concomitant medications were not reported. He received no other vaccine in four weeks. On 21Dec2020 23:00 he experienced fatigue and chills around and pain at site of injection and took Advil 600mg taken for relief. On 22Dec2020 08:00 he experienced chills, body aches, muscle soreness, headache, swollen lymph nodes, and pain at injection site was worsening; tender to touch but no inflammation. On 22Dec2020 12:00 he experienced cold sweat and on 22Dec2020 he experienced insomnia, and took Tylenol 1,000mg. On 22Dec2020 21:30 the symptoms were less severe and took Advil 600mg. On 23Dec2020 05:00 all symptoms resolved. The patient was not diagnosed with COVID-19 prior to vaccination and was not Covid tested post vaccination. The patient recovered from all events in Dec2020. The reporter assessed the events as non-serious.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Cold sweat, Fatigue, Headache, Injection site pain
Clinical narrative: Pain at site of injection; cold sweat; body aches; muscle soreness; Headache; swollen lymph nodes; pain at injection site was worsening; tender to touch but no inflammation; Insomnia; Fatigue; chills; This is a spontaneous report from a contactable nurse (patient).  A 29-year-old male patient received the 1at dose of bnt162b2 (BNT162B2, lot #: EJ1685) intramuscular at single dose at left arm on 21Dec2020 10:45 PM for Covid-19 immunization, administered at hospital.  Medical history included none. No known allergies. The patient's concomitant medications were not reported. He received no other vaccine in four weeks. On 21Dec2020 23:00 he experienced fatigue and chills around and pain at site of injection and took Advil 600mg taken for relief. On 22Dec2020 08:00 he experienced chills, body aches, muscle soreness, headache, swollen lymph nodes, and pain at injection site was worsening; tender to touch but no inflammation. On 22Dec2020 12:00 he experienced cold sweat and on 22Dec2020 he experienced insomnia, and took Tylenol 1,000mg. On 22Dec2020 21:30 the symptoms were less severe and took Advil 600mg. On 23Dec2020 05:00 all symptoms resolved. The patient was not diagnosed with COVID-19 prior to vaccination and was not Covid tested post vaccination. The patient recovered from all events in Dec2020. The reporter assessed the events as non-serious.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Lymphadenopathy, Myalgia, Pain
Clinical narrative: Pain at site of injection; cold sweat; body aches; muscle soreness; Headache; swollen lymph nodes; pain at injection site was worsening; tender to touch but no inflammation; Insomnia; Fatigue; chills; This is a spontaneous report from a contactable nurse (patient).  A 29-year-old male patient received the 1at dose of bnt162b2 (BNT162B2, lot #: EJ1685) intramuscular at single dose at left arm on 21Dec2020 10:45 PM for Covid-19 immunization, administered at hospital.  Medical history included none. No known allergies. The patient's concomitant medications were not reported. He received no other vaccine in four weeks. On 21Dec2020 23:00 he experienced fatigue and chills around and pain at site of injection and took Advil 600mg taken for relief. On 22Dec2020 08:00 he experienced chills, body aches, muscle soreness, headache, swollen lymph nodes, and pain at injection site was worsening; tender to touch but no inflammation. On 22Dec2020 12:00 he experienced cold sweat and on 22Dec2020 he experienced insomnia, and took Tylenol 1,000mg. On 22Dec2020 21:30 the symptoms were less severe and took Advil 600mg. On 23Dec2020 05:00 all symptoms resolved. The patient was not diagnosed with COVID-19 prior to vaccination and was not Covid tested post vaccination. The patient recovered from all events in Dec2020. The reporter assessed the events as non-serious.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Impaired work ability, Nausea, Palpitations
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Throat irritation
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood chloride increased, Chest X-ray normal, Discomfort, Dizziness, Dyspnoea
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Paraesthesia oral, Tachycardia, Taste disorder, Throat irritation
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Nausea, Palpitations, Paraesthesia
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tachycardia, Throat irritation, Urticaria
Clinical narrative: my left eye swelled up; I developed a rash on my chest, torso, and back; palpitations; tachycardia; scratchy throat; chest tightness; severe dizziness/lightheadedness; tingling all over; hives; nausea; numbness and tingling in my right arm and leg; o~This is a spontaneous report from a contactable nurse reporting for herself.  A 38-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), lot number: EJ1685, via an unspecified route of administration, in right arm on 22Dec2020 at 14:30 (at the age of 38 years-old) as a single dose for COVID-19 immunization. The vaccine was given at a hospital. The patient had not received other vaccines in four weeks but received other medications in the past two weeks.  Medical history included Raynaud's disease, ongoing and known allergies: Sulfa drugs. The patient previously took morphine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19 nor had been tested.  The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 22Dec2020, at 1345, the patient experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea. The clinical course was as follows: Around 5 mins after receiving vaccine, she experienced palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, tingling all over, hives, nausea and went to the emergency room (ER). She was treated with diphenhydramine, famotidine, solumedrol, observed and released from the ER. 27 hours later (23Dec2020 at approximately 0300), her left eye swelled up and developed a rash on her chest, torso, and back, scratchy throat, chest tightness, dizziness, nausea, and numbness and tingling in her right arm and leg. Took diphenhydramine. The symptoms did not go away so she went to the ER again. The patient was given prednisone and observed. She was discharged with prednisone prescription and instructions to take famotidine and diphenhydramine. The clinical outcome of the events of palpitations, tachycardia, scratchy throat, chest tightness, severe dizziness/lightheadedness, numbness and tingling in her right arm and leg, hives, rash, left eye swelled up, nausea was recovered with sequelae. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chest X-ray normal, Chest discomfort, Chest pain, Computerised tomogram thorax normal
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram T wave inversion, Fibrin D dimer increased, Lymphadenopathy, Myocardial necrosis marker normal, Nausea
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation normal, Palpitations
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Chest pain, Computerised tomogram thorax normal, Condition aggravated, Electrocardiogram normal
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer increased, Headache, Laboratory test, Lymph node pain, Lymphadenopathy
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pain in extremity, Troponin
Clinical narrative: Arm soreness , mild muscle aches, and headache on day one. On day 2, started having chest pain in middle of chest at sternum. Muscle aches and moderate headache persisted. On day 3 , Saturday, after no relief, presented at ER for chest around 4 pm. Discharged a few hours later. On day 7, Tuesday, went to follow up with primary physician at clinic. Chest pain was persisting. New development in noticing very swollen lymph nodes under each arm. Received steroid injection and follow up appointment for the next Tuesday. On day 14, chest pain has fully resolved. Lymph nodes only minor sensitivity. Told by primary physician to plan to take second dose but will monitor side effects very closely.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle tightness, Pharyngeal paraesthesia
Clinical narrative: experiencing tingling sensation in my throat and some tightness; experiencing tingling sensation in my throat and some tightness; This is a spontaneous report from a non-contactable pharmacist. A 41-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK5730), via an unspecified route of administration on 22Dec2020 15:30 at SINGLE DOSE (right arm, dose number 1) for COVID-19 immunization. The patient has no medical history. The patient's concomitant medications were not reported. Patient has no known allergies. The patient experienced experiencing tingling sensation in her throat and some tightness on 22Dec2020 15:30, 1 to 2 minutes after vaccine administration. After 10 min symptoms started going away and completely disappeared in 30 minutes. Patient did not had other vaccine in four weeks nor other medications in two weeks. Patient has no prior COVID vaccination and was not tested for COVID post vaccination. Patient is not pregnant. Treatment was not received. Outcome of the event was recovered on 22Dec2020 16:00. Events were reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal paraesthesia, Throat tightness
Clinical narrative: experiencing tingling sensation in my throat and some tightness; experiencing tingling sensation in my throat and some tightness; This is a spontaneous report from a non-contactable pharmacist. A 41-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK5730), via an unspecified route of administration on 22Dec2020 15:30 at SINGLE DOSE (right arm, dose number 1) for COVID-19 immunization. The patient has no medical history. The patient's concomitant medications were not reported. Patient has no known allergies. The patient experienced experiencing tingling sensation in her throat and some tightness on 22Dec2020 15:30, 1 to 2 minutes after vaccine administration. After 10 min symptoms started going away and completely disappeared in 30 minutes. Patient did not had other vaccine in four weeks nor other medications in two weeks. Patient has no prior COVID vaccination and was not tested for COVID post vaccination. Patient is not pregnant. Treatment was not received. Outcome of the event was recovered on 22Dec2020 16:00. Events were reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Tachycardia
Clinical narrative: had some difficulty swallowing but no SOB; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient (Pregnant: no) was received first dose of BNT162B2 (brand: Pfizer, lot number: unknown) via intramuscular on arm left 23Dec2020 10:45 AM at single dose for COVID-19 immunization. Medical history included Hypertension (HTN), OSA using CPAP. There are other medications in two weeks and no other vaccine in four weeks. No Known allergies. Patient waited at hospital after given vaccine. 1hr20mins later, had some difficulty swallowing but no SOB on23Dec2020 12:15 PM. Went to nearest ED to be seen. the most recent COVID-19 vaccine was administered in Hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Treatment received from the event included diphenhydramine hydrochloride (BENADRYL) and methylprednisolone sodium succinate (SOLUMEDROL). Patient was recovering from the event. It was reported as non-serious. No results in death, life threatening, caused/prolonged hospitalization, disabling/Incapacitating nor congenital anomaly/birth defect.  Information about lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia
Clinical narrative: had some difficulty swallowing but no SOB; This is a spontaneous report from a contactable nurse (patient). A 48-year-old female patient (Pregnant: no) was received first dose of BNT162B2 (brand: Pfizer, lot number: unknown) via intramuscular on arm left 23Dec2020 10:45 AM at single dose for COVID-19 immunization. Medical history included Hypertension (HTN), OSA using CPAP. There are other medications in two weeks and no other vaccine in four weeks. No Known allergies. Patient waited at hospital after given vaccine. 1hr20mins later, had some difficulty swallowing but no SOB on23Dec2020 12:15 PM. Went to nearest ED to be seen. the most recent COVID-19 vaccine was administered in Hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Treatment received from the event included diphenhydramine hydrochloride (BENADRYL) and methylprednisolone sodium succinate (SOLUMEDROL). Patient was recovering from the event. It was reported as non-serious. No results in death, life threatening, caused/prolonged hospitalization, disabling/Incapacitating nor congenital anomaly/birth defect.  Information about lot/batch number has been requested.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus
Clinical narrative: I was treated at the emergency department after receiving the covid 19 injection which I had an anaphylactic response. I was given Solu-Medrol IV and an EPI injection to get some relief from the swelling of my throat and tongue and facial swelling. I was treated there until I was able to regain my voice and some of the swellings had subsided. I was released home to continue my recovery and continue my oral medications.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Aphonia, Pharyngeal swelling, Swelling face, Swollen tongue
Clinical narrative: I was treated at the emergency department after receiving the covid 19 injection which I had an anaphylactic response. I was given Solu-Medrol IV and an EPI injection to get some relief from the swelling of my throat and tongue and facial swelling. I was treated there until I was able to regain my voice and some of the swellings had subsided. I was released home to continue my recovery and continue my oral medications.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Imaging procedure, Nasal congestion, Pharyngeal swelling, Throat irritation
Clinical narrative: funny feeling in her throat...Initially feeling was at the back of her tongue and then it progressed down her throat; swelling in her nose...throat and nose were swollen; swelling in her nose...throat and nose were swollen; chest was tight; This is a spontaneous report from a contactable Pharmacist. A 33-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via intramuscular on left arm on 21Dec2020 at 08:15 AM at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient returned home around 11 am on 21Dec2020 and noticed she had a funny feeling in her throat. Patient took Benadryl 50 mg and slept for at least 3 hours. When patient woke up she stated the feeling in her throat had returned. Initially feeling was at the back of her tongue and then it progressed down her throat. Patient also described a swelling in her nose. Patient presented to ED. She described that her throat and nose were swollen and chest was tight. Patient given solumedrol 125 mg IM and a prescription for prednisone 20 mg BIDx 5 days. Symptoms improved. Imaging of neck soft tissue performed: impression the superficial soft tissues appear grossly normal. No prevertebral soft tissue swelling. Airways appear widely patent. The patient had Nasal Swab on 21Dec2020 and the Covid test result showed negative. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovered on unspecified date in Dec2020.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Nasal oedema, Oropharyngeal discomfort, Pharyngeal swelling, SARS-CoV-2 test negative
Clinical narrative: funny feeling in her throat...Initially feeling was at the back of her tongue and then it progressed down her throat; swelling in her nose...throat and nose were swollen; swelling in her nose...throat and nose were swollen; chest was tight; This is a spontaneous report from a contactable Pharmacist. A 33-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), via intramuscular on left arm on 21Dec2020 at 08:15 AM at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The patient returned home around 11 am on 21Dec2020 and noticed she had a funny feeling in her throat. Patient took Benadryl 50 mg and slept for at least 3 hours. When patient woke up she stated the feeling in her throat had returned. Initially feeling was at the back of her tongue and then it progressed down her throat. Patient also described a swelling in her nose. Patient presented to ED. She described that her throat and nose were swollen and chest was tight. Patient given solumedrol 125 mg IM and a prescription for prednisone 20 mg BIDx 5 days. Symptoms improved. Imaging of neck soft tissue performed: impression the superficial soft tissues appear grossly normal. No prevertebral soft tissue swelling. Airways appear widely patent. The patient had Nasal Swab on 21Dec2020 and the Covid test result showed negative. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovered on unspecified date in Dec2020.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Feeling hot, Pruritus
Clinical narrative: body started to feel hot; itchy; extremely uncomfortable; This is a spontaneous report from a contactable Nurse (patient) .  A 52-year-old male patient received,at hospital, the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot# EJ1685) intramuscular on arm right on 18Dec2020 (at 09:15 AM) at a single dose for COVID-19 immunization. No Allergies to medications, food, or other products; No other Medical history. No Covid prior vaccination and no covid test vaccination provided . List of any other medications the patient received within 2 weeks of vaccination included: Turmeric, Ginger, Fish oil, Fiber capsules, OTC Testosterone booster. Approximately at 8pm on 19Dec2020, body started to feel hot, itchy, then became extremely uncomfortable, took Benadryl 50mg, continued every 6hrs, on Sunday 20Dec2020 at noon went to emergency department.  Pepcid and Claritin were given , an advised to continue Benadryl, the symptoms remained severe in the patient's case, extremely itchy, feeling hot, no rash noted, on 21Dec2020. He was prescribed with  hydroxyzine, he had been taking all these medications and as of now 23Dec2020 he was feeling the same, extremely itchy, hot feeling, no rash, called employer and taking off work. The patient had have appointment on  28Dec2020 with allergist. He had never had allergic reactions to vaccines.The outcome of the events was not recovered at the time of the reports.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Feeling hot, Impaired work ability, Pruritus
Clinical narrative: body started to feel hot; itchy; extremely uncomfortable; This is a spontaneous report from a contactable Nurse (patient) .  A 52-year-old male patient received,at hospital, the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot# EJ1685) intramuscular on arm right on 18Dec2020 (at 09:15 AM) at a single dose for COVID-19 immunization. No Allergies to medications, food, or other products; No other Medical history. No Covid prior vaccination and no covid test vaccination provided . List of any other medications the patient received within 2 weeks of vaccination included: Turmeric, Ginger, Fish oil, Fiber capsules, OTC Testosterone booster. Approximately at 8pm on 19Dec2020, body started to feel hot, itchy, then became extremely uncomfortable, took Benadryl 50mg, continued every 6hrs, on Sunday 20Dec2020 at noon went to emergency department.  Pepcid and Claritin were given , an advised to continue Benadryl, the symptoms remained severe in the patient's case, extremely itchy, feeling hot, no rash noted, on 21Dec2020. He was prescribed with  hydroxyzine, he had been taking all these medications and as of now 23Dec2020 he was feeling the same, extremely itchy, hot feeling, no rash, called employer and taking off work. The patient had have appointment on  28Dec2020 with allergist. He had never had allergic reactions to vaccines.The outcome of the events was not recovered at the time of the reports.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood pressure increased, Dizziness, Dysphagia, Electrocardiogram
Clinical narrative: patient reports throat tingling 10 mins post vaccination. Patient given 50mg of IM Benadryl. Rapid response team called 12/21/2020 9:44 AM Rapid response team called. EKG showed sinus tachycardia; rate 105; reports burning sensation in the throat and anxiety; lungs clear; 100% 02 sats; taken to the ED for further evaluation  In ED given prednisone and fluids, symptoms resolved patient discharged home from ED
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Pharyngeal paraesthesia, Throat irritation
Clinical narrative: patient reports throat tingling 10 mins post vaccination. Patient given 50mg of IM Benadryl. Rapid response team called 12/21/2020 9:44 AM Rapid response team called. EKG showed sinus tachycardia; rate 105; reports burning sensation in the throat and anxiety; lungs clear; 100% 02 sats; taken to the ED for further evaluation  In ED given prednisone and fluids, symptoms resolved patient discharged home from ED
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Electrocardiogram abnormal, Pharyngeal paraesthesia, Sinus tachycardia, Throat irritation
Clinical narrative: patient reports throat tingling 10 mins post vaccination. Patient given 50mg of IM Benadryl. Rapid response team called 12/21/2020 9:44 AM Rapid response team called. EKG showed sinus tachycardia; rate 105; reports burning sensation in the throat and anxiety; lungs clear; 100% 02 sats; taken to the ED for further evaluation  In ED given prednisone and fluids, symptoms resolved patient discharged home from ED
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperaesthesia, Hypoaesthesia
Clinical narrative: discomfort going up left side of neck; discomfort going up left side of neck to left side of her face; face area has numbness and tingling from left ear to mid left cheek and around left eye; Face area has numbness; This is a spontaneous report from a contactable nurse reported for herself.  A 56-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech Covid-19 vacccine, lot number: EK5730), via an unspecified route of administration on 23Dec2020 15:30 at single dose on left arm for COVID-19 immunization.  Medical history was none. Concomitant medications included multivitamin, antihistamine. The patient reported that about one hour after injection (23Dec2020 16:00) developed discomfort going up left side of neck to left side of her face. Face area has numbness and tingling from left ear to mid left cheek and around left eye. No other neurological deficit. Sensation continued at time of reporting. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No covid prior vaccination and no covid tested post vaccination. No treatment was received for the events. The outcome of the events was not resolved. The reporter assessed the events as non-serious.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Facial discomfort, Hypoaesthesia, Musculoskeletal discomfort, Paraesthesia
Clinical narrative: discomfort going up left side of neck; discomfort going up left side of neck to left side of her face; face area has numbness and tingling from left ear to mid left cheek and around left eye; Face area has numbness; This is a spontaneous report from a contactable nurse reported for herself.  A 56-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech Covid-19 vacccine, lot number: EK5730), via an unspecified route of administration on 23Dec2020 15:30 at single dose on left arm for COVID-19 immunization.  Medical history was none. Concomitant medications included multivitamin, antihistamine. The patient reported that about one hour after injection (23Dec2020 16:00) developed discomfort going up left side of neck to left side of her face. Face area has numbness and tingling from left ear to mid left cheek and around left eye. No other neurological deficit. Sensation continued at time of reporting. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No covid prior vaccination and no covid tested post vaccination. No treatment was received for the events. The outcome of the events was not resolved. The reporter assessed the events as non-serious.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Feeling hot, Headache, Hot flush, Hyperhidrosis
Clinical narrative: Patient states that around 1500 he began having nausea and headache that worsened as the day went on.  He took Tylenol and went to bed around 2300.  At about 0100 he woke up shaking, sweating, temp 99.5, confusion and eye pain.  His symptoms kept him awake for about 3 hours.  He took another Tylenol during this time and when back to bed.  The next day he had chills and it took until 12/25/20 for him to feel "normal" again.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Tremor
Clinical narrative: Patient states that around 1500 he began having nausea and headache that worsened as the day went on.  He took Tylenol and went to bed around 2300.  At about 0100 he woke up shaking, sweating, temp 99.5, confusion and eye pain.  His symptoms kept him awake for about 3 hours.  He took another Tylenol during this time and when back to bed.  The next day he had chills and it took until 12/25/20 for him to feel "normal" again.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Eye pain, Headache, Hyperhidrosis, Nausea
Clinical narrative: Patient states that around 1500 he began having nausea and headache that worsened as the day went on.  He took Tylenol and went to bed around 2300.  At about 0100 he woke up shaking, sweating, temp 99.5, confusion and eye pain.  His symptoms kept him awake for about 3 hours.  He took another Tylenol during this time and when back to bed.  The next day he had chills and it took until 12/25/20 for him to feel "normal" again.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Tremor
Clinical narrative: Patient states that around 1500 he began having nausea and headache that worsened as the day went on.  He took Tylenol and went to bed around 2300.  At about 0100 he woke up shaking, sweating, temp 99.5, confusion and eye pain.  His symptoms kept him awake for about 3 hours.  He took another Tylenol during this time and when back to bed.  The next day he had chills and it took until 12/25/20 for him to feel "normal" again.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Injection site pain
Clinical narrative: dizzy; heavy headache; sweating; chilly; a little muscle pain (like flu symptoms); a little muscle pain (like flu symptoms); pain at injection site; This is a spontaneous report from a contactable pharmacist (patient herself). A 63-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK5730), via an unspecified route of administration on 22Dec2020 14:15 in left arm at single dose for covid-19 immunization. Medical history included high blood pressure and high cholesterol. Concomitant medication included lisinopril, atorvastatin, hctz, ergocalciferol (VIT D) and vitamin b complex (VIT B COMPLEX). The patient previously took levetiracetam (KEPPRA) and experienced allergies. The most recent COVID-19 vaccine was administered at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. 5 hours after Covid vaccinated, patient had sweating, chilly, a little muscle pain (like flu symptoms), and pain at injection site on 22Dec2020 19:00. The next day (23Dec2020), still moderate pain at injection site and she felt dizzy and heavy headache for 3 hours; after that, all symptoms were gone. She took paracetamol (TYLENOL) 500mg by mouth twice a day to relieve pain (muscle pain). No treatment was received for other events. All events were reported as non-serious. Outcome of all events were revered on Dec2020.   No follow up attempts are possible. No further information is expected.